Search

Displaying results 5401 - 5410 of 8575 in total
  1. Drug

    Azeliragon

    go.drugbank.com/drugs/DB12689
    Investigational

    Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.

  2. Drug

    Talviraline

    go.drugbank.com/drugs/DB07885
    Investigational

    Talviraline has been used in trials studying the treatment of HIV Infections.

  3. Drug

    Emivirine

    go.drugbank.com/drugs/DB08188
    Investigational

    Emivirine has been used in trials studying the treatment of HIV Infections.

  4. Drug

    Pyridoxamine

    go.drugbank.com/drugs/DB11673
    Investigational

    Pyridoxamine has been used in trials studying the treatment of Kidney Stones.

  5. Drug

    Endostar

    go.drugbank.com/drugs/DB11727
    Investigational

    Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.

  6. Drug

    Depatuxizumab mafodotin

    go.drugbank.com/drugs/DB11731
    Investigational

    Depatuxizumab/Denintuzumab mafodotin has been used in trials studying the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors, and Glioblastoma Multiforme.

  7. Drug

    Spebrutinib

    go.drugbank.com/drugs/DB11764
    Investigational

    Spebrutinib has been used in trials studying the treatment of Rheumatoid Arthritis, Lymphoma, Large B-Cell, Diffuse, and Leukemia Lymphocytic Chronic B-Cell.

  8. Drug

    TMC-647055

    go.drugbank.com/drugs/DB11822
    Investigational

    TMC647055 has been used in trials studying the treatment of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, and Chronic Hepatitis C Virus.

  9. Drug

    JNJ-39393406

    go.drugbank.com/drugs/DB11867
    Investigational

    JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.

  10. Drug

    STI-1499

    go.drugbank.com/drugs/DB16487
    Investigational

    STI-1499 (COVI-GUARD was under investigation in clinical trial NCT04454398 to evaluate its safety and efficacy in patients with moderate COVID-19.